Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens

Elke Bleifuss, Henriette Bendz, Birgit Sirch, Sylvia Thompson, Anna Brandl, Valeria Milani, Michael W. Graner, Ingo Drexler, Maria Kuppner, Emmanuel Katsanis, Elfriede Noessner, Rolf Dieter Issels

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The goal of immune-based tumor therapies is the activation of immune cells reactive against a broad spectrum of tumor-expressed antigens. Vaccines based on chaperone proteins appear promising as these proteins naturally exist as complexes with various protein fragments including those derived from tumor-associated antigens. Multi-chaperone systems are expected to have highest polyvalency as different chaperones can carry distinct sets of antigenic fragments. A free-solution isoelectric focusing (FS-IEF) technique was established to generate chaperone-rich cell lysates (CRCL). Results from murine systems support the contention that CRCL induce superior anti-tumor responses than single chaperone vaccines. We established an in vitro model for human melanoma to evaluate the capacity of CRCL to transfer endogenously expressed tumor antigens to the cross-presentation pathway of dendritic cells (DC) for antigen-specific T cell stimulation. CRCL prepared from human melanoma lines contained the four major chaperone proteins Hsp/Hsc70, Hsp90, Grp94/gp96 and calreticulin. The chaperones within the melanoma cell-derived CRCL were functionally active in that they enhanced cross-presentation of exogenous peptides mixed into the CRCL preparation. Superior activity was observed for Hsp70-rich CRCL obtained from heat-stressed melanoma cells. Despite the presence of active chaperones, melanoma cell-derived CRCL failed to transfer endogenously expressed melanoma-associated antigens to DC for cross-presentation and cytotoxic T cell (CTL) recognition, even after increasing intracellular protein levels of tumor antigen or chaperones. These findings reveal limitations of the CRCL approach regarding cross-presentation of endogenously expressed melanoma-associated antigens. Yet, CRCL may be utilized as vehicles to enhance the delivery of exogenous antigens for DC-mediated cross-presentation and T cell stimulation.

Original languageEnglish (US)
Pages (from-to)623-637
Number of pages15
JournalInternational Journal of Hyperthermia
Volume24
Issue number8
DOIs
StatePublished - 2008

Fingerprint

Melanoma-Specific Antigens
Differentiation Antigens
Cross-Priming
Neoplasm Antigens
Melanoma
Dendritic Cells
T-Lymphocytes
Proteins
Vaccines
HSC70 Heat-Shock Proteins
Calreticulin
Antigens
Isoelectric Focusing

Keywords

  • Chaperone-rich cell lysate (CRCL)
  • Cross-presentation
  • Dendritic cells
  • Heat shock proteins
  • Heat shock treatment
  • Melanoma-associated antigens

ASJC Scopus subject areas

  • Cancer Research
  • Physiology
  • Radiological and Ultrasound Technology
  • Physiology (medical)

Cite this

Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens. / Bleifuss, Elke; Bendz, Henriette; Sirch, Birgit; Thompson, Sylvia; Brandl, Anna; Milani, Valeria; Graner, Michael W.; Drexler, Ingo; Kuppner, Maria; Katsanis, Emmanuel; Noessner, Elfriede; Issels, Rolf Dieter.

In: International Journal of Hyperthermia, Vol. 24, No. 8, 2008, p. 623-637.

Research output: Contribution to journalArticle

Bleifuss, E, Bendz, H, Sirch, B, Thompson, S, Brandl, A, Milani, V, Graner, MW, Drexler, I, Kuppner, M, Katsanis, E, Noessner, E & Issels, RD 2008, 'Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens', International Journal of Hyperthermia, vol. 24, no. 8, pp. 623-637. https://doi.org/10.1080/02656730802213384
Bleifuss, Elke ; Bendz, Henriette ; Sirch, Birgit ; Thompson, Sylvia ; Brandl, Anna ; Milani, Valeria ; Graner, Michael W. ; Drexler, Ingo ; Kuppner, Maria ; Katsanis, Emmanuel ; Noessner, Elfriede ; Issels, Rolf Dieter. / Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens. In: International Journal of Hyperthermia. 2008 ; Vol. 24, No. 8. pp. 623-637.
@article{84f6884e429140d89d8c42164cac1039,
title = "Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens",
abstract = "The goal of immune-based tumor therapies is the activation of immune cells reactive against a broad spectrum of tumor-expressed antigens. Vaccines based on chaperone proteins appear promising as these proteins naturally exist as complexes with various protein fragments including those derived from tumor-associated antigens. Multi-chaperone systems are expected to have highest polyvalency as different chaperones can carry distinct sets of antigenic fragments. A free-solution isoelectric focusing (FS-IEF) technique was established to generate chaperone-rich cell lysates (CRCL). Results from murine systems support the contention that CRCL induce superior anti-tumor responses than single chaperone vaccines. We established an in vitro model for human melanoma to evaluate the capacity of CRCL to transfer endogenously expressed tumor antigens to the cross-presentation pathway of dendritic cells (DC) for antigen-specific T cell stimulation. CRCL prepared from human melanoma lines contained the four major chaperone proteins Hsp/Hsc70, Hsp90, Grp94/gp96 and calreticulin. The chaperones within the melanoma cell-derived CRCL were functionally active in that they enhanced cross-presentation of exogenous peptides mixed into the CRCL preparation. Superior activity was observed for Hsp70-rich CRCL obtained from heat-stressed melanoma cells. Despite the presence of active chaperones, melanoma cell-derived CRCL failed to transfer endogenously expressed melanoma-associated antigens to DC for cross-presentation and cytotoxic T cell (CTL) recognition, even after increasing intracellular protein levels of tumor antigen or chaperones. These findings reveal limitations of the CRCL approach regarding cross-presentation of endogenously expressed melanoma-associated antigens. Yet, CRCL may be utilized as vehicles to enhance the delivery of exogenous antigens for DC-mediated cross-presentation and T cell stimulation.",
keywords = "Chaperone-rich cell lysate (CRCL), Cross-presentation, Dendritic cells, Heat shock proteins, Heat shock treatment, Melanoma-associated antigens",
author = "Elke Bleifuss and Henriette Bendz and Birgit Sirch and Sylvia Thompson and Anna Brandl and Valeria Milani and Graner, {Michael W.} and Ingo Drexler and Maria Kuppner and Emmanuel Katsanis and Elfriede Noessner and Issels, {Rolf Dieter}",
year = "2008",
doi = "10.1080/02656730802213384",
language = "English (US)",
volume = "24",
pages = "623--637",
journal = "International Journal of Hyperthermia",
issn = "0265-6736",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens

AU - Bleifuss, Elke

AU - Bendz, Henriette

AU - Sirch, Birgit

AU - Thompson, Sylvia

AU - Brandl, Anna

AU - Milani, Valeria

AU - Graner, Michael W.

AU - Drexler, Ingo

AU - Kuppner, Maria

AU - Katsanis, Emmanuel

AU - Noessner, Elfriede

AU - Issels, Rolf Dieter

PY - 2008

Y1 - 2008

N2 - The goal of immune-based tumor therapies is the activation of immune cells reactive against a broad spectrum of tumor-expressed antigens. Vaccines based on chaperone proteins appear promising as these proteins naturally exist as complexes with various protein fragments including those derived from tumor-associated antigens. Multi-chaperone systems are expected to have highest polyvalency as different chaperones can carry distinct sets of antigenic fragments. A free-solution isoelectric focusing (FS-IEF) technique was established to generate chaperone-rich cell lysates (CRCL). Results from murine systems support the contention that CRCL induce superior anti-tumor responses than single chaperone vaccines. We established an in vitro model for human melanoma to evaluate the capacity of CRCL to transfer endogenously expressed tumor antigens to the cross-presentation pathway of dendritic cells (DC) for antigen-specific T cell stimulation. CRCL prepared from human melanoma lines contained the four major chaperone proteins Hsp/Hsc70, Hsp90, Grp94/gp96 and calreticulin. The chaperones within the melanoma cell-derived CRCL were functionally active in that they enhanced cross-presentation of exogenous peptides mixed into the CRCL preparation. Superior activity was observed for Hsp70-rich CRCL obtained from heat-stressed melanoma cells. Despite the presence of active chaperones, melanoma cell-derived CRCL failed to transfer endogenously expressed melanoma-associated antigens to DC for cross-presentation and cytotoxic T cell (CTL) recognition, even after increasing intracellular protein levels of tumor antigen or chaperones. These findings reveal limitations of the CRCL approach regarding cross-presentation of endogenously expressed melanoma-associated antigens. Yet, CRCL may be utilized as vehicles to enhance the delivery of exogenous antigens for DC-mediated cross-presentation and T cell stimulation.

AB - The goal of immune-based tumor therapies is the activation of immune cells reactive against a broad spectrum of tumor-expressed antigens. Vaccines based on chaperone proteins appear promising as these proteins naturally exist as complexes with various protein fragments including those derived from tumor-associated antigens. Multi-chaperone systems are expected to have highest polyvalency as different chaperones can carry distinct sets of antigenic fragments. A free-solution isoelectric focusing (FS-IEF) technique was established to generate chaperone-rich cell lysates (CRCL). Results from murine systems support the contention that CRCL induce superior anti-tumor responses than single chaperone vaccines. We established an in vitro model for human melanoma to evaluate the capacity of CRCL to transfer endogenously expressed tumor antigens to the cross-presentation pathway of dendritic cells (DC) for antigen-specific T cell stimulation. CRCL prepared from human melanoma lines contained the four major chaperone proteins Hsp/Hsc70, Hsp90, Grp94/gp96 and calreticulin. The chaperones within the melanoma cell-derived CRCL were functionally active in that they enhanced cross-presentation of exogenous peptides mixed into the CRCL preparation. Superior activity was observed for Hsp70-rich CRCL obtained from heat-stressed melanoma cells. Despite the presence of active chaperones, melanoma cell-derived CRCL failed to transfer endogenously expressed melanoma-associated antigens to DC for cross-presentation and cytotoxic T cell (CTL) recognition, even after increasing intracellular protein levels of tumor antigen or chaperones. These findings reveal limitations of the CRCL approach regarding cross-presentation of endogenously expressed melanoma-associated antigens. Yet, CRCL may be utilized as vehicles to enhance the delivery of exogenous antigens for DC-mediated cross-presentation and T cell stimulation.

KW - Chaperone-rich cell lysate (CRCL)

KW - Cross-presentation

KW - Dendritic cells

KW - Heat shock proteins

KW - Heat shock treatment

KW - Melanoma-associated antigens

UR - http://www.scopus.com/inward/record.url?scp=57649193170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649193170&partnerID=8YFLogxK

U2 - 10.1080/02656730802213384

DO - 10.1080/02656730802213384

M3 - Article

VL - 24

SP - 623

EP - 637

JO - International Journal of Hyperthermia

JF - International Journal of Hyperthermia

SN - 0265-6736

IS - 8

ER -